It is difficult to determine an explicit cut-off value for predicting all-cause death and MACEs in patients with CKD because the range of plasma NT-proBNP values is wide, especially in the old; therefore, further study is needed to determine the best cut-off value for plasma NT-proBNP in very old patients with stage 3 CKD. This evidence concerns the gene NPPB and chronic kidney disease.